Innovent Biologics, Inc.
IVBXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,540,139 | $7,508,185 | $8,165,264 | $10,052,095 |
| Short-Term Investments | $0 | $375,555 | $463,491 | $867,534 |
| Receivables | $1,722,353 | $1,566,930 | $1,368,940 | $1,005,891 |
| Inventory | $1,128,113 | $822,167 | $690,411 | $968,088 |
| Other Curr. Assets | $702,269 | $0 | $360,552 | $484,377 |
| Total Curr. Assets | $13,092,874 | $10,272,837 | $11,048,658 | $13,427,985 |
| Property Plant & Equip (Net) | $5,601,765 | $5,647,242 | $5,420,865 | $4,656,384 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,388,342 | $1,282,603 | $987,351 | $27,788 |
| Long-Term Investments | $3,132,043 | $3,900,896 | $2,301,397 | $794,089 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $379,248 | $499,024 | $537,425 | $1,721,114 |
| Total NC Assets | $10,501,398 | $11,329,765 | $9,247,038 | $7,199,375 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $23,594,272 | $21,602,602 | $20,295,696 | $20,627,360 |
| Liabilities | – | – | – | – |
| Payables | $432,292 | $357,677 | $220,621 | $372,549 |
| Short-Term Debt | $1,114,591 | $413,929 | $1,011,711 | $1,220,330 |
| Tax Payable | $0 | $0 | $0 | $194,049 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,465,583 | $3,597,263 | $2,895,238 | $2,689,888 |
| Total Curr. Liab. | $5,012,466 | $4,368,869 | $4,127,570 | $4,476,816 |
| LT Debt | $2,264,725 | $2,417,114 | $2,337,017 | $2,400,199 |
| Deferred Rev, NC | $0 | $0 | $0 | $960,051 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,895,261 | $1,698,890 | $1,404,735 | $262,713 |
| Total NC Liab. | $4,159,986 | $4,116,004 | $3,741,752 | $3,622,963 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7,696 | $13,589 | $143,318 | $98,597 |
| Total Liabilities | $9,172,452 | $8,484,873 | $7,869,322 | $8,099,779 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $114 | $113 | $112 | $112 |
| Retained Earnings | -$15,072,047 | -$15,906,368 | -$16,160,188 | -$15,767,568 |
| AOCI | $1,304,542 | $1,301,360 | $1,042,385 | $970,541 |
| Other Equity | $28,189,211 | $27,722,624 | $27,544,065 | $27,324,496 |
| Total Equity | $14,421,820 | $13,117,729 | $12,426,374 | $12,527,581 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $23,594,272 | $21,602,602 | $20,295,696 | $20,627,360 |
| Net Debt | -$6,160,823 | -$4,677,142 | -$4,816,536 | -$6,431,566 |